Compugen reported $469.17M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 45M 339M Jun/2025
aTyr Pharma USD 60M 11M Feb/2026
Bio Path USD 3M 2M Jun/2025
Brainstorm Cell Therapeutics USD 29M 19M Jun/2025
Cara Therapeutics USD 46M 23M Jun/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
Immunic USD 68M 2M Dec/2023
Infinity Pharmaceuticals USD 19M 5M Jun/2023
Minerva Neurosciences USD 43M 5M Dec/2023
RedHill Biopharma USD 12M 17M Jun/2024
TherapeuticsMD USD 24M 0 Mar/2024